论文部分内容阅读
目的探讨凝结芽孢杆菌活菌片对轮状病毒肠炎的临床治疗效果和安全性。方法将68例轮状病毒肠炎患儿随机分为治疗组(口服凝结芽孢杆菌活菌片)和对照组(未口服凝结芽孢杆菌活菌片),疗程5天,观察两组治疗前后患儿腹泻、腹胀、脱水症状的病情变化。结果治疗组总有效率95%,腹泻、腹胀、脱水症状改善明显优于对照组,未见明显的毒副作用及不良反应。结论凝结芽孢杆菌活菌片是治疗轮状病毒肠炎有效而安全的药物。
Objective To investigate the clinical efficacy and safety of Bacillus coagulans live-borne on rotavirus enteritis. Methods Sixty-eight children with rotavirus enteritis were randomly divided into treatment group (viable Bacillus subtilis) and control group (non-oral viable Bacillus coagulans) for 5 days. The incidence of diarrhea in both groups before and after treatment , Bloating, dehydration symptoms change. Results The total effective rate of the treatment group was 95%, diarrhea, bloating and dehydration symptoms were significantly better than the control group, no obvious side effects and adverse reactions. Conclusions Bacillus coagulans viable bacterial tablet is an effective and safe drug for the treatment of rotavirus enteritis.